A chemogenetic approach for dopamine imaging with tunable sensitivity.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
02 Jul 2024
02 Jul 2024
Historique:
received:
07
11
2023
accepted:
05
06
2024
medline:
3
7
2024
pubmed:
3
7
2024
entrez:
2
7
2024
Statut:
epublish
Résumé
Genetically-encoded dopamine (DA) sensors enable high-resolution imaging of DA release, but their ability to detect a wide range of extracellular DA levels, especially tonic versus phasic DA release, is limited by their intrinsic affinity. Here we show that a human-selective dopamine receptor positive allosteric modulator (PAM) can be used to boost sensor affinity on-demand. The PAM enhances DA detection sensitivity across experimental preparations (in vitro, ex vivo and in vivo) via one-photon or two-photon imaging. In vivo photometry-based detection of optogenetically-evoked DA release revealed that DETQ administration produces a stable 31 minutes window of potentiation without effects on animal behavior. The use of the PAM revealed region-specific and metabolic state-dependent differences in tonic DA levels and enhanced single-trial detection of behavior-evoked phasic DA release in cortex and striatum. Our chemogenetic strategy can potently and flexibly tune DA imaging sensitivity and reveal multi-modal (tonic/phasic) DA signaling across preparations and imaging approaches.
Identifiants
pubmed: 38956067
doi: 10.1038/s41467-024-49442-3
pii: 10.1038/s41467-024-49442-3
doi:
Substances chimiques
Dopamine
VTD58H1Z2X
Receptors, Dopamine
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5551Subventions
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
ID : 101016787
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
ID : 310030_196455
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
ID : 310030L_212508
Informations de copyright
© 2024. The Author(s).
Références
Berke, J. D. What does dopamine mean? Nat. Neurosci. 21, 787–793 (2018).
pubmed: 29760524
pmcid: 6358212
doi: 10.1038/s41593-018-0152-y
Björklund, A. & Dunnett, S. B. Dopamine neuron systems in the brain: an update. Trends Neurosci. 30, 194–202 (2007).
pubmed: 17408759
doi: 10.1016/j.tins.2007.03.006
Zhuang, Y. et al. Structural insights into the human D1 and D2 dopamine receptor signaling complexes. Cell 184, 931–942.e18 (2021).
pubmed: 33571431
pmcid: 8215686
doi: 10.1016/j.cell.2021.01.027
Jaquins-Gerstl, A. & Michael, A. C. A review of the effects of FSCV and microdialysis measurements on dopamine release in the surrounding tissue. Analyst 140, 3696–3708 (2015).
pubmed: 25876757
pmcid: 4437820
doi: 10.1039/C4AN02065K
Sabatini, B. L. & Tian, L. Imaging Neurotransmitter and Neuromodulator Dynamics In Vivo with Genetically Encoded Indicators. Neuron 108, 17–32 (2020).
pubmed: 33058762
doi: 10.1016/j.neuron.2020.09.036
Patriarchi, T. et al. Imaging neuromodulators with high spatiotemporal resolution using genetically encoded indicators. Nat. Protoc. 14, 3471–3505 (2019).
pubmed: 31732722
doi: 10.1038/s41596-019-0239-2
Wu, Z., Lin, D. & Li, Y. Pushing the frontiers: tools for monitoring neurotransmitters and neuromodulators. Nat. Rev. Neurosci. 23, 257–274 (2022).
pubmed: 35361961
pmcid: 11163306
doi: 10.1038/s41583-022-00577-6
Labouesse, M. A. & Patriarchi, T. A versatile GPCR toolkit to track in vivo neuromodulation: not a one-size-fits-all sensor. Neuropsychopharmacology 46, 2043–2047 (2021).
Patriarchi, T. et al. Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors. Science 360, eaat4422 (2018).
pubmed: 29853555
pmcid: 6287765
doi: 10.1126/science.aat4422
Sun, F. et al. A Genetically Encoded Fluorescent Sensor Enables Rapid and Specific Detection of Dopamine in Flies, Fish, and Mice. Cell 174, 481–496.e19 (2018).
pubmed: 30007419
pmcid: 6092020
doi: 10.1016/j.cell.2018.06.042
Warne, T., Edwards, P. C., Doré, A. S., Leslie, A. G. W. & Tate, C. G. Molecular basis for high affinity agonist binding in GPCRs. Science 364, 775–778 (2019).
pubmed: 31072904
pmcid: 6586556
doi: 10.1126/science.aau5595
Labouesse, M. A., Cola, R. B. & Patriarchi, T. GPCR-Based Dopamine Sensors-A Detailed Guide to Inform Sensor Choice for In vivo Imaging. Int. J. Mol. Sci. 21, 8048 (2020).
Grace, A. A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1–24 (1991).
pubmed: 1676137
doi: 10.1016/0306-4522(91)90196-U
Dreyer, J. K., Herrik, K. F., Berg, R. W. & Hounsgaard, J. D. Influence of Phasic and Tonic Dopamine Release on Receptor Activation. J. Neurosci. 30, 14273–14283 (2010).
pubmed: 20962248
pmcid: 6634758
doi: 10.1523/JNEUROSCI.1894-10.2010
Liu, C. et al. An action potential initiation mechanism in distal axons for the control of dopamine release. Science 375, 1378–1385 (2022).
pubmed: 35324301
pmcid: 9081985
doi: 10.1126/science.abn0532
Mohebi, A., Collins, V. L. & Berke, J. D. Accumbens cholinergic interneurons dynamically promote dopamine release and enable motivation. Elife. 12, e85011 (2023).
Lewis, M. A. et al. Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity. J. Pharm. Exp. Ther. 354, 340–349 (2015).
doi: 10.1124/jpet.115.224071
Svensson, K. A., Hao, J. & Bruns, R. F. Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disorders. Adv. Pharm. 86, 273–305 (2019).
doi: 10.1016/bs.apha.2019.06.001
Luderman, K. D. et al. Identification of Positive Allosteric Modulators of the D1 Dopamine Receptor That Act at Diverse Binding Sites. Mol. Pharm. 94, 1197–1209 (2018).
doi: 10.1124/mol.118.113175
Bruns, R. F. et al. Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders. Neuropharmacology 128, 351–365 (2018).
pubmed: 29102759
doi: 10.1016/j.neuropharm.2017.10.032
Wang, X. et al. Intracellular Binding Site for a Positive Allosteric Modulator of the Dopamine D1 Receptor. Mol. Pharm. 94, 1232–1245 (2018).
doi: 10.1124/mol.118.112649
Zhuang, Y. et al. Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor. Cell Res 31, 593–596 (2021).
pubmed: 33750903
pmcid: 8089099
doi: 10.1038/s41422-021-00482-0
Xiao, P. et al. Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes. Cell 184, 943–956.e18 (2021).
pubmed: 33571432
pmcid: 11005940
doi: 10.1016/j.cell.2021.01.028
Svensson, K. A. et al. An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis. J. Pharm. Exp. Ther. 360, 117–128 (2017).
doi: 10.1124/jpet.116.236372
Hao, J. et al. Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1S,3R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor. J. Med. Chem. 62, 8711–8732 (2019).
pubmed: 31532644
doi: 10.1021/acs.jmedchem.9b01234
Dixon, A. S. et al. NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells. ACS Chem. Biol. 11, 400–408 (2016).
pubmed: 26569370
doi: 10.1021/acschembio.5b00753
Kagiampaki, Z. et al. Sensitive multicolor indicators for monitoring norepinephrine in vivo. Nat Methods 20, 1426–1436 (2023).
Elizarova, S. et al. A fluorescent nanosensor paint detects dopamine release at axonal varicosities with high spatiotemporal resolution. Proc. Natl Acad. Sci. USA 119, e2202842119 (2022).
pubmed: 35613050
pmcid: 9295782
doi: 10.1073/pnas.2202842119
Bulumulla, C. et al. Visualizing synaptic dopamine efflux with a 2D composite nanofilm. eLife 11, e78773 (2022).
pubmed: 35786443
pmcid: 9363124
doi: 10.7554/eLife.78773
Klein Herenbrink, C. et al. Multimodal detection of dopamine by sniffer cells expressing genetically encoded fluorescent sensors. Commun. Biol. 5, 1–9 (2022).
doi: 10.1038/s42003-022-03488-5
Bäckman, C. M. et al. Characterization of a mouse strain expressing Cre recombinase from the 3’ untranslated region of the dopamine transporter locus. Genesis 44, 383–390 (2006).
pubmed: 16865686
doi: 10.1002/dvg.20228
Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133–140 (2010).
pubmed: 20023653
doi: 10.1038/nn.2467
Klapoetke, N. C. et al. Independent Optical Excitation of Distinct Neural Populations. Nat. Methods 11, 338–346 (2014).
pubmed: 24509633
pmcid: 3943671
doi: 10.1038/nmeth.2836
Podda, M. V., Riccardi, E., D’Ascenzo, M., Azzena, G. B. & Grassi, C. Dopamine D1-like receptor activation depolarizes medium spiny neurons of the mouse nucleus accumbens by inhibiting inwardly rectifying K+ currents through a cAMP-dependent protein kinase A-independent mechanism. Neuroscience 167, 678–690 (2010).
pubmed: 20211700
doi: 10.1016/j.neuroscience.2010.02.075
Meltzer, H. Y. et al. The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice. Behav. Brain Res 361, 139–150 (2019).
pubmed: 30521930
doi: 10.1016/j.bbr.2018.12.006
Rajagopal, L. et al. The dopamine D1 receptor positive allosteric modulator, DETQ, improves cognition and social interaction in aged mice and enhances cortical and hippocampal acetylcholine efflux. Behav. Brain Res 459, 114766 (2024).
pubmed: 38048913
doi: 10.1016/j.bbr.2023.114766
de Jong, J. W. et al. A Neural Circuit Mechanism for Encoding Aversive Stimuli in the Mesolimbic Dopamine System. Neuron 101, 133–151.e7 (2019).
pubmed: 30503173
doi: 10.1016/j.neuron.2018.11.005
Liu, Z. et al. A distinct D1-MSN subpopulation down-regulates dopamine to promote negative emotional state. Cell Res 32, 139–156 (2022).
pubmed: 34848869
doi: 10.1038/s41422-021-00588-5
Salinas, A. G. et al. Distinct sub-second dopamine signaling in dorsolateral striatum measured by a genetically-encoded fluorescent sensor. Nat. Commun. 14, 5915 (2023).
pubmed: 37739964
pmcid: 10517008
doi: 10.1038/s41467-023-41581-3
Mohebi, A. et al. Dissociable dopamine dynamics for learning and motivation. Nature 570, 65–70 (2019).
pubmed: 31118513
pmcid: 6555489
doi: 10.1038/s41586-019-1235-y
Roth, B. L. DREADDs for Neuroscientists. Neuron 89, 683–694 (2016).
pubmed: 26889809
pmcid: 4759656
doi: 10.1016/j.neuron.2016.01.040
Bonaventura, J. et al. High-potency ligands for DREADD imaging and activation in rodents and monkeys. Nat. Commun. 10, 4627 (2019).
pubmed: 31604917
pmcid: 6788984
doi: 10.1038/s41467-019-12236-z
Gradinaru, V., Thompson, K. R. & Deisseroth, K. eNpHR: a Natronomonas halorhodopsin enhanced for optogenetic applications. Brain Cell Biol. 36, 129–139 (2008).
pubmed: 18677566
pmcid: 2588488
doi: 10.1007/s11068-008-9027-6
Wallace, C. W., Loudermilt, M. C. & Fordahl, S. C. Effect of fasting on dopamine neurotransmission in subregions of the nucleus accumbens in male and female mice. Nutr. Neurosci. 25, 1338–1349 (2022).
pubmed: 33297887
doi: 10.1080/1028415X.2020.1853419
Sych, Y., Chernysheva, M., Sumanovski, L. T. & Helmchen, F. High-density multi-fiber photometry for studying large-scale brain circuit dynamics. Nat. Methods 16, 553–560 (2019).
pubmed: 31086339
doi: 10.1038/s41592-019-0400-4
Sych, Y., Fomins, A., Novelli, L. & Helmchen, F. Dynamic reorganization of the cortico-basal ganglia-thalamo-cortical network during task learning. Cell Rep. 40, 111394 (2022).
pubmed: 36130513
pmcid: 9513804
doi: 10.1016/j.celrep.2022.111394
Vander Weele, C. M. et al. Dopamine enhances signal-to-noise ratio in cortical-brainstem encoding of aversive stimuli. Nature 563, 397–401 (2018).
doi: 10.1038/s41586-018-0682-1
Herenbrink, C. K. et al. Multimodal detection of dopamine by sniffer cells expressing genetically encoded fluorescent sensors. Commun Biol. 5, 578 (2022).
Condon, A. F. et al. The residence of synaptically released dopamine on D2 autoreceptors. Cell Rep. 36, 109465 (2021).
pubmed: 34348146
pmcid: 8351352
doi: 10.1016/j.celrep.2021.109465
Jørgensen, S. H. et al. Behavioral encoding across timescales by region-specific dopamine dynamics. Proc. Natl Acad. Sci. USA 120, e2215230120 (2023).
pubmed: 36749722
pmcid: 9963838
doi: 10.1073/pnas.2215230120
Li, J. & Mooney, D. J. Designing hydrogels for controlled drug delivery. Nat. Rev. Mater. 1, 1–17 (2016).
doi: 10.1038/natrevmats.2016.71
Kedir, W. M., Deresa, E. M. & Diriba, T. F. Pharmaceutical and drug delivery applications of pectin and its modified nanocomposites. Heliyon 8, e10654 (2022).
pubmed: 36164543
pmcid: 9508417
doi: 10.1016/j.heliyon.2022.e10654
Bernhard, S. & Tibbitt, M. W. Supramolecular engineering of hydrogels for drug delivery. Adv. Drug Deliv. Rev. 171, 240–256 (2021).
pubmed: 33561451
doi: 10.1016/j.addr.2021.02.002
Cunningham, M. G., O’Connor, R. P. & Wong, S. E. Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents. J Vis Exp 17, 716 (2008).
Zhuo, Y. et al. Improved green and red GRAB sensors for monitoring dopaminergic activity in vivo. Nat. Methods 21, 680–691 (2024).
Liu, C., Goel, P. & Kaeser, P. S. Spatial and temporal scales of dopamine transmission. Nat. Rev. Neurosci. 22, 345–358 (2021).
pubmed: 33837376
pmcid: 8220193
doi: 10.1038/s41583-021-00455-7
Sulzer, D., Cragg, S. J. & Rice, M. E. Striatal dopamine neurotransmission: regulation of release and uptake. Basal Ganglia 6, 123–148 (2016).
pubmed: 27141430
pmcid: 4850498
doi: 10.1016/j.baga.2016.02.001
Owesson-White, C. A. et al. Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens: Extracellular dopamine concentration. J. Neurochem. 121, 252–262 (2012).
pubmed: 22296263
pmcid: 3323736
doi: 10.1111/j.1471-4159.2012.07677.x
Kim, H. R. et al. A Unified Framework for Dopamine Signals across Timescales. Cell 183, 1600–1616.e25 (2020).
pubmed: 33248024
pmcid: 7736562
doi: 10.1016/j.cell.2020.11.013
Wang, Y., Toyoshima, O., Kunimatsu, J., Yamada, H. & Matsumoto, M. Tonic firing mode of midbrain dopamine neurons continuously tracks reward values changing moment-by-moment. eLife 10, e63166 (2021).
Mikhael, J. G., Lai, L. & Gershman, S. J. Rational inattention and tonic dopamine. PLOS Comput. Biol. 17, e1008659 (2021).
pubmed: 33760806
pmcid: 7990190
doi: 10.1371/journal.pcbi.1008659
Delignat-Lavaud, B. et al. Synaptotagmin-1-dependent phasic axonal dopamine release is dispensable for basic motor behaviors in mice. Nat. Commun. 14, 4120 (2023).
pubmed: 37433762
pmcid: 10336101
doi: 10.1038/s41467-023-39805-7
Iino, Y. et al. Dopamine D2 receptors in discrimination learning and spine enlargement. Nature 579, 555–560 (2020).
pubmed: 32214250
doi: 10.1038/s41586-020-2115-1
Ellwood, I. T. et al. Tonic or Phasic Stimulation of Dopaminergic Projections to Prefrontal Cortex Causes Mice to Maintain or Deviate from Previously Learned Behavioral Strategies. J. Neurosci. 37, 8315–8329 (2017).
pubmed: 28739583
pmcid: 5577850
doi: 10.1523/JNEUROSCI.1221-17.2017
Grieder, T. E. et al. Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal. Proc. Natl Acad. Sci. 109, 3101–3106 (2012).
pubmed: 22308372
pmcid: 3286981
doi: 10.1073/pnas.1114422109
Schultz, W., Dayan, P. & Montague, P. R. A neural substrate of prediction and reward. Science 275, 1593–1599 (1997).
pubmed: 9054347
doi: 10.1126/science.275.5306.1593
Cohen, J. Y., Haesler, S., Vong, L., Lowell, B. B. & Uchida, N. Neuron-type-specific signals for reward and punishment in the ventral tegmental area. Nature 482, 85–88 (2012).
pubmed: 22258508
pmcid: 3271183
doi: 10.1038/nature10754
Hart, A. S., Rutledge, R. B., Glimcher, P. W. & Phillips, P. E. M. Phasic dopamine release in the rat nucleus accumbens symmetrically encodes a reward prediction error term. J. Neurosci. 34, 698–704 (2014).
pubmed: 24431428
pmcid: 3891951
doi: 10.1523/JNEUROSCI.2489-13.2014
Steinberg, E. E. et al. A causal link between prediction errors, dopamine neurons and learning. Nat. Neurosci. 16, 966–973 (2013).
pubmed: 23708143
pmcid: 3705924
doi: 10.1038/nn.3413
Jeong, H. et al. Mesolimbic dopamine release conveys causal associations. Science 378, eabq6740 (2022).
pubmed: 36480599
pmcid: 9910357
doi: 10.1126/science.abq6740
Robinson, B. G. et al. RIM is essential for stimulated but not spontaneous somatodendritic dopamine release in the midbrain. eLife 8, e47972 (2019).
pubmed: 31486769
pmcid: 6754207
doi: 10.7554/eLife.47972
Yorgason, J. T., Zeppenfeld, D. M. & Williams, J. T. Cholinergic Interneurons Underlie Spontaneous Dopamine Release in Nucleus Accumbens. J. Neurosci. 37, 2086 (2017).
pubmed: 28115487
pmcid: 5338756
doi: 10.1523/JNEUROSCI.3064-16.2017
Liu, C. & Kaeser, P. S. Mechanisms and regulation of dopamine release. Curr. Opin. Neurobiol. 57, 46–53 (2019).
pubmed: 30769276
pmcid: 6629510
doi: 10.1016/j.conb.2019.01.001
Massengill, C. I. et al. Sensitive genetically encoded sensors for population and subcellular imaging of cAMP in vivo. Nat. Methods 19, 1461–1471 (2022).
pubmed: 36303019
pmcid: 10171401
doi: 10.1038/s41592-022-01646-5
Ma, L. et al. A Highly Sensitive A-Kinase Activity Reporter for Imaging Neuromodulatory Events in Awake Mice. Neuron 99, 665–679.e5 (2018).
pubmed: 30100256
pmcid: 6152931
doi: 10.1016/j.neuron.2018.07.020
Zhang, J.-F. et al. An ultrasensitive biosensor for high-resolution kinase activity imaging in awake mice. Nat. Chem. Biol. 17, 39–46 (2021).
pubmed: 32989297
doi: 10.1038/s41589-020-00660-y
Foster, D. J. & Conn, P. J. Allosteric modulation of GPCRs: new insights and potential utility for treatment of schizophrenia and other CNS disorders. Neuron 94, 431–446 (2017).
pubmed: 28472649
pmcid: 5482176
doi: 10.1016/j.neuron.2017.03.016
Wan, Q. et al. Mini G protein probes for active G protein–coupled receptors (GPCRs) in live cells. J. Biol. Chem. 293, 7466–7473 (2018).
pubmed: 29523687
pmcid: 5949987
doi: 10.1074/jbc.RA118.001975
Fasano, C., Thibault, D. & Trudeau, L.-E. Culture of postnatal mesencephalic dopamine neurons on an astrocyte monolayer. Curr. Protoc. Neurosci. Chapter 3, Unit 3.21 (2008).
pubmed: 18633997
van Brakel, J. P. G. Robust peak detection algorithm using z-scores. Stack Overflow 36, 2787–2795 (2014).
Thoeni, S., Loureiro, M., O’Connor, E. C. & Lüscher, C. Depression of Accumbal to Lateral Hypothalamic Synapses Gates Overeating. Neuron 107, 158–172.e4 (2020).
pubmed: 32333845
doi: 10.1016/j.neuron.2020.03.029
Kalvass, J. C., Maurer, T. S. & Pollack, G. M. Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios. Drug Metab. Dispos. 35, 660–666 (2007).
pubmed: 17237155
doi: 10.1124/dmd.106.012294
Duffet, L. et al. A photocaged orexin-B for spatiotemporally precise control of orexin signaling. Cell Chem. Biol. 29, 1729–1738.e8 (2022).
Mathis, A. et al. DeepLabCut: markerless pose estimation of user-defined body parts with deep learning. Nat. Neurosci. 21, 1281–1289 (2018).
pubmed: 30127430
doi: 10.1038/s41593-018-0209-y
Labouesse, M. A. et al. A non-canonical triatopallidal Go pathway that supports motor control. Nat Commun 14, 6712 (2023).
Salinas, A. G. et al. Distinct sub-second dopamine signaling in dorsolateral striatum measured by a genetically-encoded fluorescent sensor. Nat Commun. 14, 5915 (2023).
Patriarchi Lab. PatriarchiLab/InVivoPhotometry: 1. [object Object] https://doi.org/10.5281/ZENODO.11262981 (2024).
Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat Methods 9, 679–682 (2022).